STAGE IVA LARYNGEAL CANCER AJCC V8
Clinical trials for STAGE IVA LARYNGEAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA LARYNGEAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA LARYNGEAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo attack on tough head & neck cancers
Disease control Not yet recruitingThis early-stage trial is testing whether a new drug called camonsertib, combined with a precise form of radiation therapy, can help control head and neck cancers that have returned or cannot be surgically removed. The main goals are to find the safest dose of the drug-radiation …
Matched conditions: STAGE IVA LARYNGEAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for patients who Can't take standard chemo
Disease control Not yet recruitingThis study aims to find the best treatment for people with advanced head and neck cancer who cannot safely take the standard chemotherapy drug, cisplatin. It will compare two different drug combinations, each given alongside targeted radiation therapy, in about 454 patients. The …
Matched conditions: STAGE IVA LARYNGEAL CANCER AJCC V8
Phase: PHASE3 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 11, 2026 14:52 UTC